Skip to main content

Table 4 Performance of the GB kit in the presence of interfering compounds

From: Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan

SpecimenInterfering compoundmean COI±std. Dev.p-value
SerumTG (−)3.65±0.600.87
TG (+)3.59±0.09
BL (−)2.95±0.830.77
BL (+)2.75±0.67
HB (−)3.85±0.380.62
HB (+)3.68±0.40
HAMA (−)3.60±0.160.43
HAMA (+)3.80±0.35
MAPC (−)3.26±0.490.20
MAPC (+)3.89±0.52
EDTA-treated plasmaTG (−)4.09±0.600.24
TG (+)3.57±0.23
BL (−)3.65±0.840.48
BL (+)3.24±0.39
HB (−)4.59±0.260.03
HB (+)3.90±0.26
HAMA (−)4.67±0.270.23
HAMA (+)4.43±0.11
MAPC (−)4.09±0.090.01
MAPC (+)5.02±0.30
  1. TG triglyceride, BL bilirubin, HB hemoglobin, HAMA human anti-mouse antibody plasma, MAPC multi-analyte positive control (SeraCare Accurun Series 2700)